Lars Ottosson

1.7k total citations
30 papers, 1.0k citations indexed

About

Lars Ottosson is a scholar working on Immunology, Rheumatology and Molecular Biology. According to data from OpenAlex, Lars Ottosson has authored 30 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 11 papers in Rheumatology and 9 papers in Molecular Biology. Recurrent topics in Lars Ottosson's work include Advanced Glycation End Products research (9 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Cell Adhesion Molecules Research (5 papers). Lars Ottosson is often cited by papers focused on Advanced Glycation End Products research (9 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Cell Adhesion Molecules Research (5 papers). Lars Ottosson collaborates with scholars based in Sweden, United States and United Kingdom. Lars Ottosson's co-authors include Jan Andersson, Lena Klevenvall, Karin Palmblad, Hanna Schierbeck, Marie Wahren‐Herlenius, Helena Erlandsson Harris, Maria Sunnerhagen, Vijay K. Kuchroo, Peter Lundbäck and Therese Östberg and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

Lars Ottosson

29 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lars Ottosson Sweden 17 495 322 258 245 107 30 1.0k
Kiyoki Kitagawa Japan 18 429 0.9× 61 0.2× 312 1.2× 222 0.9× 105 1.0× 35 1.5k
H. P. Schwarz Austria 23 377 0.8× 113 0.4× 335 1.3× 94 0.4× 226 2.1× 43 1.9k
Sang Eun Lee South Korea 17 149 0.3× 136 0.4× 257 1.0× 64 0.3× 45 0.4× 47 1.0k
Shaun A. Summers Australia 21 819 1.7× 41 0.1× 247 1.0× 200 0.8× 97 0.9× 33 1.4k
Wilco P. Pulskens Netherlands 15 565 1.1× 113 0.4× 734 2.8× 42 0.2× 59 0.6× 18 1.6k
Hao Dun United States 15 223 0.5× 266 0.8× 191 0.7× 44 0.2× 32 0.3× 27 810
Piero Tanganelli Italy 17 139 0.3× 320 1.0× 225 0.9× 49 0.2× 116 1.1× 31 1.7k
Jong Sung Park South Korea 5 494 1.0× 362 1.1× 425 1.6× 15 0.1× 66 0.6× 14 1.3k
Tin Kyaw Australia 27 2.0k 4.1× 82 0.3× 648 2.5× 404 1.6× 90 0.8× 38 2.7k
Jiřı́ Vácha Czechia 18 126 0.3× 67 0.2× 211 0.8× 62 0.3× 135 1.3× 39 873

Countries citing papers authored by Lars Ottosson

Since Specialization
Citations

This map shows the geographic impact of Lars Ottosson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Ottosson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Ottosson more than expected).

Fields of papers citing papers by Lars Ottosson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Ottosson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Ottosson. The network helps show where Lars Ottosson may publish in the future.

Co-authorship network of co-authors of Lars Ottosson

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Ottosson. A scholar is included among the top collaborators of Lars Ottosson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Ottosson. Lars Ottosson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sandvik, Ulrika, et al.. (2024). Management and outcomes of foramen magnum stenosis in children with achondroplasia at a single center over 15 years. Journal of Neurosurgery Pediatrics. 34(5). 470–478.
2.
Chau, Michael, Ellie Landman, Masaru Kanekiyo, et al.. (2022). The synovial microenvironment suppresses chondrocyte hypertrophy and promotes articular chondrocyte differentiation. npj Regenerative Medicine. 7(1). 51–51. 13 indexed citations
3.
Yang, Huan, Peter Lundbäck, Lars Ottosson, et al.. (2021). Redox modifications of cysteine residues regulate the cytokine activity of HMGB1. Molecular Medicine. 27(1). 58–58. 41 indexed citations
4.
Gkourogianni, Alexandra, et al.. (2021). Rat perichondrium transplanted to articular cartilage defects forms articular-like, hyaline cartilage. Bone. 151. 116035–116035. 5 indexed citations
5.
6.
Lee, John D., et al.. (2019). Therapeutic blockade of HMGB1 reduces early motor deficits, but not survival in the SOD1G93A mouse model of amyotrophic lateral sclerosis. Journal of Neuroinflammation. 16(1). 45–45. 20 indexed citations
7.
Lundberg, Johan, Lena Klevenvall, Peter Damberg, et al.. (2018). Neuroinflammation in Response to Intracerebral Injections of Different HMGB1 Redox Isoforms. Journal of Innate Immunity. 10(3). 215–227. 40 indexed citations
8.
Claesson, Andreas, Johan Herlitz, Leif Svensson, et al.. (2017). Defibrillation before EMS arrival in western Sweden. The American Journal of Emergency Medicine. 35(8). 1043–1048. 26 indexed citations
9.
Gunasekaran, Manoj Kumar, Cynthia Planesse, Alexis Guérin-Dubourg, et al.. (2016). TLR4-dependant pro-inflammatory effects of HMGB1 on human adipocyte. Adipocyte. 5(4). 384–388. 21 indexed citations
10.
Wirestam, Lina, Hanna Schierbeck, Thomas Skogh, et al.. (2015). Antibodies against High Mobility Group Box protein-1 (HMGB1) versus other anti-nuclear antibody fine-specificities and disease activity in systemic lupus erythematosus. Arthritis Research & Therapy. 17(1). 338–338. 25 indexed citations
11.
Ottosson, Lars, Peter Lundbäck, Hulda S. Hreggvidsdottir, et al.. (2012). The pro-inflammatory effect of HMGB1, a mediator of inflammation in arthritis, is dependent on the redox status of the protein. Annals of the Rheumatic Diseases. 71. A81–A82. 1 indexed citations
12.
Schierbeck, Hanna, Peter Lundbäck, Karin Palmblad, et al.. (2011). Monoclonal Anti-HMGB1 (High Mobility Group Box Chromosomal Protein 1) Antibody Protection in Two Experimental Arthritis Models. Molecular Medicine. 17(9-10). 1039–1044. 106 indexed citations
13.
Strandberg, Linn, Aurélie Ambrosi, Maja Jagodic, et al.. (2010). Maternal MHC Regulates Generation of Pathogenic Antibodies and Fetal MHC-Encoded Genes Determine Susceptibility in Congenital Heart Block. The Journal of Immunology. 185(6). 3574–3582. 21 indexed citations
14.
Strandberg, Linn, Aurélie Ambrosi, Alexander Espinosa, et al.. (2007). Interferon-α Induces Up-regulation and Nuclear Translocation of the Ro52 Autoantigen as Detected by a Panel of Novel Ro52-specific Monoclonal Antibodies. Journal of Clinical Immunology. 28(3). 220–231. 102 indexed citations
15.
Ottosson, Lars, et al.. (2006). The Ile128Thr polymorphism influences stability and ligand binding properties of the microsomal triglyceride transfer protein. Journal of Lipid Research. 47(7). 1378–1385. 20 indexed citations
16.
Ottosson, Lars, Stina Salomonsson, Janosch Hennig, et al.. (2005). Structurally Derived Mutations Define Congenital Heart Block‐Related Epitopes Within the 200–239 Amino Acid Stretch of the Ro52 Protein. Scandinavian Journal of Immunology. 61(2). 109–118. 17 indexed citations
17.
Hennig, Janosch, Lars Ottosson, Cecilia Andrésen, et al.. (2005). Structural Organization and Zn2+-dependent Subdomain Interactions Involving Autoantigenic Epitopes in the Ring-B-box-Coiled-coil (RBCC) Region of Ro52. Journal of Biological Chemistry. 280(39). 33250–33261. 23 indexed citations
18.
Salomonsson, Stina, Sven‐Erik Sonesson, Lars Ottosson, et al.. (2005). Ro/SSA autoantibodies directly bind cardiomyocytes, disturb calcium homeostasis, and mediate congenital heart block. The Journal of Experimental Medicine. 201(1). 11–17. 122 indexed citations
19.
Lundberg, Karin, et al.. (2004). A pH-induced modification of CII increases its arthritogenic properties. Journal of Autoimmunity. 23(2). 95–102. 4 indexed citations
20.
Salomonsson, Stina, Lars Ottosson, Daniëlle Hof, et al.. (2004). Cloning and characterization of two human Ro52-specific monoclonal autoantibodies directed towards a domain associated with congenital heart block. Journal of Autoimmunity. 22(2). 167–177. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kiyoki Kitagawa Breakdown of academic impact, for papers by H. P. Schwarz Breakdown of academic impact, for papers by Sang Eun Lee Breakdown of academic impact, for papers by Shaun A. Summers Breakdown of academic impact, for papers by Wilco P. Pulskens Breakdown of academic impact, for papers by Hao Dun Breakdown of academic impact, for papers by Piero Tanganelli Breakdown of academic impact, for papers by Jong Sung Park Breakdown of academic impact, for papers by Tin Kyaw Breakdown of academic impact, for papers by Jiřı́ Vácha
Rankless by CCL
2026